Background: The detection of impaired physical performance in older adults with cardiovascular disease is essential for clinical management and therapeutic decision-making. There is a requirement for an assessment tool that can be used conveniently, rapidly, and securely in clinical practice for screening decreased physical performance. Objective: The present study was performed to evaluate the association of office-based physical assessments with decreased physical performance and to compare the prognostic capability of these assessments in older adults with cardiovascular disease. Methods: A total of 1,040 patients aged 75 years and older with cardiovascular disease were included in this analysis. One-leg standing time (OLST) and handgrip strength were measured as office-based physical assessment tools, and short physical performance battery (SPPB), 6-min walk distance, and usual gait speed were also measured at hospital discharge as measurements of physical performance. All-cause mortality was assessed by death registry at the hospital. We examined the association of office-based measures with physical performance and all-cause mortality. Results: The areas under the curve of OLST for SPPB < 10, 6-min walk distance < 300 m, and usual gait speed < 1.0 m/s were 0.87 (95% CI 0.83–0.91), 0.83 (95% CI 0.80–0.86), and 0.81 (95% CI 0.78–0.85), respectively. The discrimination abilities of OLST for decreased physical performance were significantly higher than those of handgrip strength. After adjusting for the effects of patient characteristics, the hazard ratio for all-cause mortality in the < 3 s group for OLST was 1.68 (95% CI 1.06–2.67, p = 0.03). Handgrip strength, however, was not significantly associated with mortality risk in these participants. Conclusion: Short OLST, in particular < 3 s, is associated with decreased physical performance and elevated mortality risk in elderly patients with cardiovascular disease. OLST can be conveniently measured in the clinician’s office as a screening tool for impaired physical performance.

1.
Fried
LP
,
Tangen
CM
,
Walston
J
,
Newman
AB
,
Hirsch
C
,
Gottdiener
J
, et al.
Cardiovascular Health Study Collaborative Research G. Frailty in older adults: evidence for a phenotype
.
J Gerontol A Biol Sci Med Sci
.
2001
;
56
(
3
):
146
56
. 1079-5006
2.
Denfeld
QE
,
Winters-Stone
K
,
Mudd
JO
,
Gelow
JM
,
Kurdi
S
,
Lee
CS
.
The prevalence of frailty in heart failure: A systematic review and meta-analysis
.
Int J Cardiol
.
2017
Jun
;
236
:
283
9
.
[PubMed]
0167-5273
3.
Collard
RM
,
Boter
H
,
Schoevers
RA
,
Oude Voshaar
RC
.
Prevalence of frailty in community-dwelling older persons: a systematic review
.
J Am Geriatr Soc
.
2012
Aug
;
60
(
8
):
1487
92
.
[PubMed]
0002-8614
4.
Kojima
G
,
Iliffe
S
,
Taniguchi
Y
,
Shimada
H
,
Rakugi
H
,
Walters
K
.
Prevalence of frailty in Japan: A systematic review and meta-analysis
.
J Epidemiol
.
2017
Aug
;
27
(
8
):
347
53
.
[PubMed]
0917-5040
5.
Sepehri
A
,
Beggs
T
,
Hassan
A
,
Rigatto
C
,
Shaw-Daigle
C
,
Tangri
N
, et al.
The impact of frailty on outcomes after cardiac surgery: a systematic review
.
J Thorac Cardiovasc Surg
.
2014
Dec
;
148
(
6
):
3110
7
.
[PubMed]
0022-5223
6.
Rodríguez-Pascual
C
,
Paredes-Galán
E
,
Ferrero-Martínez
AI
,
Gonzalez-Guerrero
JL
,
Hornillos-Calvo
M
,
Menendez-Colino
R
, et al.
The frailty syndrome is associated with adverse health outcomes in very old patients with stable heart failure: A prospective study in six Spanish hospitals
.
Int J Cardiol
.
2017
Jun
;
236
:
296
303
.
[PubMed]
0167-5273
7.
Rodríguez-Pascual
C
,
Paredes-Galán
E
,
Ferrero-Martínez
AI
,
Baz-Alonso
JA
,
Durán-Muñoz
D
,
González-Babarro
E
, et al.
The frailty syndrome and mortality among very old patients with symptomatic severe aortic stenosis under different treatments
.
Int J Cardiol
.
2016
Dec
;
224
:
125
31
.
[PubMed]
0167-5273
8.
Sanchis
J
,
Bonanad
C
,
Ruiz
V
,
Fernández
J
,
García-Blas
S
,
Mainar
L
, et al.
Frailty and other geriatric conditions for risk stratification of older patients with acute coronary syndrome
.
Am Heart J
.
2014
Nov
;
168
(
5
):
784
91
.
[PubMed]
0002-8703
9.
Kamiya
K
,
Masuda
T
,
Tanaka
S
,
Hamazaki
N
,
Matsue
Y
,
Mezzani
A
, et al.
Quadriceps Strength as a Predictor of Mortality in Coronary Artery Disease
.
Am J Med
.
2015
Nov
;
128
(
11
):
1212
9
.
[PubMed]
0002-9343
10.
Afilalo
J
,
Kim
S
,
O’Brien
S
,
Brennan
JM
,
Edwards
FH
,
Mack
MJ
, et al.
Gait Speed and Operative Mortality in Older Adults Following Cardiac Surgery
.
JAMA Cardiol
.
2016
Jun
;
1
(
3
):
314
21
.
[PubMed]
2380-6583
11.
Ohara
M
,
Kohara
K
,
Okada
Y
,
Ochi
M
,
Nagai
T
,
Ohyagi
Y
, et al.
Office-based simple frailty score and central blood pressure predict mild cognitive impairment in an apparently healthy Japanese population: J-SHIPP study
.
Sci Rep
.
2017
Apr
;
7
(
1
):
46419
.
[PubMed]
2045-2322
12.
Tabara
Y
,
Kohara
K
,
Ochi
M
,
Okada
Y
,
Ohara
M
,
Nagai
T
, et al.
Association of office-based frailty score with hypertensive end organ damage in the J-SHIPP cross-sectional study
.
Int J Cardiol
.
2016
Aug
;
216
:
25
31
.
[PubMed]
0167-5273
13.
Bouillanne
O
,
Morineau
G
,
Dupont
C
,
Coulombel
I
,
Vincent
JP
,
Nicolis
I
, et al.
Geriatric Nutritional Risk Index: a new index for evaluating at-risk elderly medical patients
.
Am J Clin Nutr
.
2005
Oct
;
82
(
4
):
777
83
.
[PubMed]
0002-9165
14.
Guralnik
JM
,
Simonsick
EM
,
Ferrucci
L
,
Glynn
RJ
,
Berkman
LF
,
Blazer
DG
, et al.
A short physical performance battery assessing lower extremity function: association with self-reported disability and prediction of mortality and nursing home admission
.
J Gerontol
.
1994
Mar
;
49
(
2
):
M85
94
.
[PubMed]
0022-1422
15.
Guralnik
JM
,
Ferrucci
L
,
Pieper
CF
,
Leveille
SG
,
Markides
KS
,
Ostir
GV
, et al.
Lower extremity function and subsequent disability: consistency across studies, predictive models, and value of gait speed alone compared with the short physical performance battery
.
J Gerontol A Biol Sci Med Sci
.
2000
Apr
;
55
(
4
):
M221
31
.
[PubMed]
1079-5006
16.
ATS Committee on Proficiency Standards for Clinical Pulmonary Function Laboratories
.
ATS statement: guidelines for the six-minute walk test
.
Am J Respir Crit Care Med
.
2002
Jul
;
166
(
1
):
111
7
.
[PubMed]
1073-449X
17.
Bajraktari
G
,
Elezi
S
,
Berisha
V
,
Lindqvist
P
,
Rexhepaj
N
,
Henein
MY
.
Left ventricular asynchrony and raised filling pressure predict limited exercise performance assessed by 6 minute walk test
.
Int J Cardiol
.
2011
Feb
;
146
(
3
):
385
9
.
[PubMed]
0167-5273
18.
Reeves
GR
,
Whellan
DJ
,
Duncan
P
,
O’Connor
CM
,
Pastva
AM
,
Eggebeen
JD
, et al.;
REHAB-HF Trial Investigators
.
Rehabilitation Therapy in Older Acute Heart Failure Patients (REHAB-HF) trial: design and rationale
.
Am Heart J
.
2017
Mar
;
185
:
130
9
.
[PubMed]
0002-8703
19.
Xanthos
PD
,
Gordon
BA
,
Kingsley
MI
.
Implementing resistance training in the rehabilitation of coronary heart disease: A systematic review and meta-analysis
.
Int J Cardiol
.
2017
Mar
;
230
:
493
508
.
[PubMed]
0167-5273
20.
Svensson
LG
,
Adams
DH
,
Bonow
RO
,
Kouchoukos
NT
,
Miller
DC
,
O’Gara
PT
, et al.
Aortic valve and ascending aorta guidelines for management and quality measures: executive summary
.
Ann Thorac Surg
.
2013
Apr
;
95
(
4
):
1491
505
.
[PubMed]
0003-4975
21.
Ponikowski
P
,
Voors
AA
,
Anker
SD
,
Bueno
H
,
Cleland
JG
,
Coats
AJ
, et al.;
ESC Scientific Document Group
.
2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: the Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC)Developed with the special contribution of the Heart Failure Association (HFA) of the ESC
.
Eur Heart J
.
2016
Jul
;
37
(
27
):
2129
200
.
[PubMed]
0195-668X
22.
Bongue
B
,
Dupré
C
,
Beauchet
O
,
Rossat
A
,
Fantino
B
,
Colvez
A
.
A screening tool with five risk factors was developed for fall-risk prediction in community-dwelling elderly
.
J Clin Epidemiol
.
2011
Oct
;
64
(
10
):
1152
60
.
[PubMed]
0895-4356
23.
Shimada
H
,
Suzukawa
M
,
Tiedemann
A
,
Kobayashi
K
,
Yoshida
H
,
Suzuki
T
.
Which neuromuscular or cognitive test is the optimal screening tool to predict falls in frail community-dwelling older people?
Gerontology
.
2009
;
55
(
5
):
532
8
.
[PubMed]
0304-324X
24.
Tabara
Y
,
Okada
Y
,
Ohara
M
,
Uetani
E
,
Kido
T
,
Ochi
N
, et al.
Association of postural instability with asymptomatic cerebrovascular damage and cognitive decline: the Japan Shimanami health promoting program study
.
Stroke
.
2015
Jan
;
46
(
1
):
16
22
.
[PubMed]
0039-2499
25.
Hupin
D
,
Roche
F
,
Gremeaux
V
,
Chatard
JC
,
Oriol
M
,
Gaspoz
JM
, et al.
Even a low-dose of moderate-to-vigorous physical activity reduces mortality by 22% in adults aged ≥60 years: a systematic review and meta-analysis
.
Br J Sports Med
.
2015
Oct
;
49
(
19
):
1262
7
.
[PubMed]
0306-3674
26.
Zwisler
AD
,
Norton
RJ
,
Dean
SG
,
Dalal
H
,
Tang
LH
,
Wingham
J
, et al.
Home-based cardiac rehabilitation for people with heart failure: A systematic review and meta-analysis
.
Int J Cardiol
.
2016
Oct
;
221
:
963
9
.
[PubMed]
0167-5273
27.
Anderson
L
,
Oldridge
N
,
Thompson
DR
,
Zwisler
AD
,
Rees
K
,
Martin
N
, et al.
Exercise-Based Cardiac Rehabilitation for Coronary Heart Disease: Cochrane Systematic Review and Meta-Analysis
.
J Am Coll Cardiol
.
2016
Jan
;
67
(
1
):
1
12
.
[PubMed]
0735-1097
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.